Press Releases
Palleon Pharmaceuticals Presents Initial Phase 1 Results from the GLIMMER-01 Clinical Trial for E-602, the First Ever Glyco-Immune Checkpoint Inhibitor
Palleon Pharmaceuticals to Present at the Guggenheim Healthcare Talks Oncology Day
Palleon Announces Issuance of a U.S. Patent for Use of Antibody Sialidase Conjugates
Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase
In the News
Novel strategy of attacking sugars on cancer cells to free immune system shows promise in early tests
STAT
Palleon unveils PhI look at ‘lawn mower’ approach to glycoimmunology: #AACR23
Endpoints
What A Nobel Prize-Winner’s Research Means for Cancer Treatment
MedCity News
Stanford’s Carolyn Bertozzi, 2022 Nobel Laureate in Chemistry, on translational science
Stanford School of Humanities and Sciences
Social Media
Glycoscience is a field with global reach. @ozglyco is a network for Australian glycoscientists to come together to… http://rQBNcFjjCD
Palleon is proud to be a part of something truly life-changing: clinical research. We are advancing our GLIMMER-01… http://IvHG4OWhUk